Help_for_Today_2-2017

research within the CMT community, and it is the only CMT-specific patient advocacy organization in the United States strategically aligned with the National Institutes of Health Rare Disease Clinical Research

2018_CMTA_Annual_Report_2

…is a non-profit organization dedicated to finding a cure for CMT. The CMTA’s Strategy to Accelerate Research (STAR) program brings top researchers together with pharmaceutical and biotechnology partners and patients…

Denver Summit Program_ONLINE FINAL 9.4.24

…and scientists charged with shaping and delivering the CMTA’s research strategies. The CMTA currently has more than 50 active research proj- ects, including sponsored research grants with academic labs and…

2017_Fall_CMTA_Report

…to walk, run, dance and enjoy life to the fullest.” CMT1A research is part of CMTA’s Strategy to Accelerate Research (STAR) program that puts top researchers together with pharmaceutical partners—and…

2017_Fall_CMTA_Report

…to walk, run, dance and enjoy life to the fullest.” CMT1A research is part of CMTA’s Strategy to Accelerate Research (STAR) program that puts top researchers together with pharmaceutical partners—and…

CMTAreportSpring2022

…inform a more general therapeutic strategy for dominant CMT2E. All the CMTA’s research efforts are consolidated under the banner of STAR—which brings together the world’s largest network of biotech research

About the Charcot-Marie-Tooth Association

…funding initiatives lies CMTA’s Strategy to Accelerate Research (STAR), bringing the best CMT researchers, clinicians, and experts in therapy development together with pharmaceutical and biotechnology companies and patients to expedite…

Pete Foley Joins CMTA Board of Directors

…nerves die, the muscles around them follow suit. All of the CMTA’s research efforts are consolidated under the banner of STAR—which brings together the world’s largest network of biotech research